Sinensetin is one of the polymethoxyflavones (PMFs) having five methoxy groups on the basic benzo--pyrone skeleton with a carbonyl group at the C 4 position. We investigated in this study the anti-inflammatory activity of sinensetin in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Sinensetin showed anti-inflammatory activity by regulating the protein level of inhibitor B-(IB-).
Polymethoxyflavones (PMFs), which are unique to citrus plants, are of particular interest because of their biological effects which include lipoprotein metabolism modulation, anti-inflammatory activity, and anti-oxidative activity. [1] [2] [3] [4] Most studies on PMFs have been focused on nobiletin and tangeretin, reports on the biological activities of sinensetin being rare. Sinensetin is one of the polymethoxyflavones (PMFs) and has five methoxy groups on the basic benzo--pyrone (15-carbon, C 6 -C 3 -C 6 ) skeleton with a carbonyl group at the C 4 position.
5) The present study examines the antiinflammatory effect of sinensetin on LPS-stimulated RAW 264.7 macrophage cells.
Inflammation is a local, protective response to microbial invasion or injury. An excessive inflammation response causes morbidity and mortality in diseases. 6) Macrophages are activated during an inflammatory response by such stimuli as LPS and TNF-. 7) This activation of macrophages damages both the pathogen and the host by inducing such pro-inflammatory mediators as NO, IL-1, IL-6, TNF-, iNOS and COX-2. 6) We first investigated the effect of sinensetin on the production of these inflammatory mediators in LPSstimulated RAW 264.7 cells. The appropriate concentration (50 mM as the maximal treatment concentration) for treating RAW 264.7 cells was determined by MTT and LDH assays (data not shown). Figure 1 indicates that pre-treating with sinensetin for 1 h inhibited the secretion of NO and the protein expression of iNOS and COX-2 in a dose-dependent manner ( Fig. 1A and B) . The levels of such pro-inflammatory cytokines as IL-1, IL-6, and TNF-mRNA were also attenuated by pretreating LPS-stimulated RAW 264.7 cells with sinensetin (50 mM) for 1 h (Fig. 1C) . The inflammatory mediators are associated with the level of the inflammatory response, so that their effective regulation is essential. 8, 9) Our results indicate that sinensetin exerted its antiinflammatory activities by inhibiting many inflammatory mediators.
LPS produces inflammatory mediators by activating the MAPK and NF-B pathways and then inducing inflammation in macrophages. 7, 10, 11) We consequently examined the effect of sinensetin on these pathways. The MAPK pathway reacts to diverse extracellular stimuli and regulates various cellular activities related to the expression of pro-inflammatory mediators. 11, 12) However, sinensetin did not affect the phosphorylation of MAPK (data not shown).
The NF-B pathway can be activated in response to pro-inflammatory stimuli, involving the degradation of inhibitor B (IB) by the IB kinase (IKK) complex. The free NF-B dimers translocate to the nucleus, where they bind to specific sequences in the promoter or enhancer regions of the target genes. 13, 14) Activated NF-B can be terminated by both the export of nuclear NF-B and degradation of p65 in the nucleus. 15) We therefore examined the effect of sinensetin on the level of IB-and the nuclear localization of p65. Figure 2A shows that IB-completely disappeared within 10 min from the whole cell extract without any pre-treatment with sinensetin, and then re-appeared within 40 min of an LPS treatment. However, pretreating with sinensetin (50 mM) significantly delayed the LPS-induced IB-disappearance and also enhanced its re-appearance.
Stabilizing IB-is important for suppressing excessive inflammation, because binding to IB-prevents the NF-B complex translocating from the cytoplasm to the nucleus. 16, 17) We therefore investigated the effect of sinensetin on the nuclear translocation of the p65 subunit of NF-B after its release from IBby examining the level of p65 protein in both the cytoplasmic and nuclear fractions. The nuclear level of p65 in the cells that had been pre-treated with sinensetin (50 mM) decreased within 50 min of the LPS treatment, unlike the level in cells that had been treated y To whom correspondence should be addressed. Tel: +82-64-754-3529; Fax: +82-64-756-3541; E-mail: sjkim@jejunu.ac.kr Abbreviations: COX-2, cyclooxygenase-2; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; IKK, IB kinase; IL-1, interleukin-1; IL-6, interleukin-6; iNOS, inducible nitric oxide synthase; IB-, inhibitor B-; LDH, lactate dehydrogenase; LPS, lipopolysaccharide; MAPK, mitogen-activated protein kinase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; NO, nitric oxide; NF-B, nuclear transcription factor kappa-B; PBS, phosphate-buffered saline; PDTC, pyrrolidine dithiocarbamate; PMF, polymethoxyflavone; SD, standard deviation; TNF-, tumor necrosis factor-with LPS alone (Fig. 2B ), although the difference in cytoplasmic level of p65 in the two groups was not detected in this assay. The effect of sinensetin on the nuclear translocation of the NF-B p65 subunit was also clearly confirmed by immunocytochemistry (data not shown). These results suggest that sinensetin affected NF-B p65 translocation by regulating the protein level of IB-, although its underlying molecular mechanism was not revealed in this study. There has recently been increased interest and efforts in the search for antiinflammatory agent to suppress the expression of proinflammatory genes by inhibiting the NF-B activation pathway. 18, 19) A natural NF-B inhibitor may therefore be useful for developing therapeutic drugs to control the inflammation associated with human diseases in a clinical environment.
In conclusion, we have shown that sinensetin inhibited the expression of genes associated with inflammation (iNOS, COX-2, IL-1, IL-6, and TNF-) by regulating the IB-protein level in LPS-activated macrophages. This results suggests that sinensetin could be beneficial in the treatment of inflammation-related diseases.
Experimental
Sinensetin was obtained from ChromaDex (Irvine, CA, USA) and dissolved in DMSO. DMEM, fetal bovine serum (FBS), and antibiotics were obtained from Gibco BRL (Grand Island, NY, USA). The antibody against iNOS was purchased from Calbiochem (San Diego, CA, USA), and the antibody against COX-2 was obtained from BD (Mountain View, CA, USA). The antibodies to IB-and NF-B p65 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and LPS (Escherichia coli 026:B6) was purchased from Sigma (St. Louis, MO, USA). The RAW 264.7 murine macrophage cells (Korea Cell Line Bank, Seoul, Korea) were maintained in DMEM supplemented with antibiotics and 10% FBS at 37 C in a 5% CO 2 incubator. Measurement of the nitrite production, the western blot analysis, total RNA extraction and real-time PCR were performed as previously described. 20) The cytoplasmic and nuclear extracts were prepared as described 21) with some modifications. Each result is expressed as the mean AE SD, and p values were determined by using the paired t-test; p < 0:05 is considered to be statistically significant. 
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